BioSig Technologies, Inc. entered into a Securities Purchase Agreement with certain accredited and institutional investors in a private placement offering to issue 2,607,170 shares and warrants to purchase up to 1,303,585 shares of Common Stock at a purchase price of $0.3989 per Share for gross proceeds of $1,040,000.113 on January 12, 2024. The Warrants have an exercise price of $0.3364 per share to purchase one-half of a Share, will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance. The securities were sold in reliance on the exemption from registration provided by section 4(a)(2) of the securities act of 1933 and Regulation D. The transaction included from 7 investors.